Pirfenidone Capsules in the Treatment of Radiation-induced Lung Injury With or Without Immune Pneumonia
Clinical trial NCT07388680 · RECRUITING
Trial details
- NCT number
- NCT07388680
- Sponsor
- Beijing Continent Pharmaceutical Co, Ltd.
- Status
- RECRUITING
- Phase
- Phase 2, Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-03-26
- Primary completion
- 2026-12-30
- Enrollment
- 298
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.